| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/2003 | EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 02/05/2003 | EP1027329B1 Dofetilide polymorphs |
| 02/05/2003 | EP1019062B1 Osteoblast-specific mitogens and drugs containing such compounds |
| 02/05/2003 | EP1014960B1 Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing |
| 02/05/2003 | EP1003486B1 Pharmaceutical compositions containing an effervescent acid-base couple |
| 02/05/2003 | EP0996429B1 Solid state solutions and dispersions of poorly water soluble drugs |
| 02/05/2003 | EP0993433B1 Method for producing calcium pyruvates |
| 02/05/2003 | EP0984960B1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists |
| 02/05/2003 | EP0980242B1 Use of fumaric acid derivatives for the treatment of autoimmune diseases |
| 02/05/2003 | EP0938311B1 Use of efaroxan for producing medicine for treating huntington disease |
| 02/05/2003 | EP0934277B1 Process for the preparation of n- 2-(dimethylamino)ethyl]acridine-4-carboxamide |
| 02/05/2003 | EP0918523B1 Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders |
| 02/05/2003 | EP0848706B1 Substituted benzene-fused heterocyclics as neurokinin antagonists |
| 02/05/2003 | EP0841913B1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
| 02/05/2003 | EP0841904B1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 02/05/2003 | EP0841903B1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 02/05/2003 | EP0817632B1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/05/2003 | EP0814797B1 Parenteral pharmaceutical compositions containing alkylammonium salts of 2-arylpropionic acids |
| 02/05/2003 | EP0802782B1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 02/05/2003 | EP0794787B1 Compositions for the treatment of parasitic and fungal infections |
| 02/05/2003 | EP0745087B1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents |
| 02/05/2003 | CN1395613A 抗微生物组合物 The antimicrobial composition |
| 02/05/2003 | CN1395580A Human cystine knot polypeptide |
| 02/05/2003 | CN1395579A Method for synthesis of alpha-D-GA (1-3) GAL-containing oligosaccharides |
| 02/05/2003 | CN1395578A Byrido [2,3-d] pyrimidine-2, 7-diamine kinase inhibitors |
| 02/05/2003 | CN1395577A Ethanol solvate of (-)-cis-2-2(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-1methyl) piperidinyl]-4H-1-benzopyran-4-one |
| 02/05/2003 | CN1395576A Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one |
| 02/05/2003 | CN1395575A Novel piperidine compounds and drugs containing the same |
| 02/05/2003 | CN1395574A Food product and producing method |
| 02/05/2003 | CN1395573A Extraction of flavonoids |
| 02/05/2003 | CN1395571A Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 02/05/2003 | CN1395569A Oxazolidinone thioamides with piperazine amide substituents |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1395567A New imidazole derivatives |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395565A Indole derivatives as MCP-1 receptor antagonists |
| 02/05/2003 | CN1395564A Indole derivatives as MCP-1 receptor antagonists |
| 02/05/2003 | CN1395563A Isatine derivatives with neurotrophic activity |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395560A Glyburide composition |
| 02/05/2003 | CN1395558A Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 02/05/2003 | CN1395556A Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate |
| 02/05/2003 | CN1395555A Calcium dicarboxylate ethers, method of making same, and treatment of vascular disease and diabetes therewith |
| 02/05/2003 | CN1395490A Antigen-specific IgE antibody production inhibitors |
| 02/05/2003 | CN1395488A Drospirenone for hormone replacement therapy |
| 02/05/2003 | CN1395487A The use of mirtazapine for treatment of sleep disorders |
| 02/05/2003 | CN1395486A Drug combination for treatment of depression and related disorders comprising mirtazapine and gepirone |
| 02/05/2003 | CN1395485A Water soluble prodrugs of azole compounds |
| 02/05/2003 | CN1395484A Substances for use in treating psoriasis |
| 02/05/2003 | CN1395483A Anti-microbial compositions comprising salt of transition metal chelator |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1394867A Medicinal oligose and its preparation method and medicine composition containing said oligose |
| 02/05/2003 | CN1394860A 3-phenyl-3.7-diazobicyclo [3,3,1] nonane compound and its preparation method and medicine containing it |
| 02/05/2003 | CN1394858A Cycermanone quaternary antifungal compound |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1394853A Levobubikain carbonate and its preparation |
| 02/05/2003 | CN1394643A Medicine for curing subacute thyroiditis |
| 02/05/2003 | CN1394639A General anesthesia resuscitantanaleptic medicine |
| 02/05/2003 | CN1394631A Health-care food for resisting fatigue |
| 02/05/2003 | CN1394626A Medicine for curing burn |
| 02/05/2003 | CN1394625A Inflammation-relieving medicine |
| 02/05/2003 | CN1394610A Herapin calcium eye drops |
| 02/05/2003 | CN1394609A Puerarin oral preparation and its preparation method |
| 02/05/2003 | CN1394608A Injection sterile powder containing erythromycin salt and M cholinergic receptor-blocking agent and its preparation method |
| 02/05/2003 | CN1394607A Buxining oral disintegrant tablet for curing angina pectoris and its preparation method |
| 02/05/2003 | CN1394606A Nifedipine drop pill preparation and its making method |
| 02/05/2003 | CN1394605A Nimodipine oral disintegrant tablet for curing dementia and its preparation method |
| 02/05/2003 | CN1394604A Indapamide slowly-releasing tablet |
| 02/05/2003 | CN1394603A Application of hydroxyethyl puerarin in preparation of new medicine for curing cerebrovascular diseases |
| 02/05/2003 | CN1394602A Benzoic acid substituted benzopyran fro curing atheroscleorsis |
| 02/05/2003 | CN1394601A Joint chemical therapy method |
| 02/05/2003 | CN1394598A Dosage form with crispness coating and soft kernel |
| 02/05/2003 | CN1394597A Process for preparing powder preparation |
| 02/05/2003 | CN1394595A Dicaine foaming compound anesthetic |
| 02/05/2003 | CN1394594A Amino acid derivative base compound and application and method for dissolving material with low solubility |
| 02/05/2003 | CN1394520A Method for producing sugar-reducing soluble granules richly containing alpha-linolenic acid, lecithin and trivalent chromium |
| 02/05/2003 | CN1100779C 3-aryl substituted pyrazolo [4,3-d] pyriidine derivatives, corticotropin-releasing factor receptor (CRF1) specific ligands |
| 02/05/2003 | CN1100778C Pyrrolopyriidines and processes for preapring thereof |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100776C Process for preparing magnesium salt of substituted sulphinyl heterocycle |
| 02/05/2003 | CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/05/2003 | CN1100773C Benzofran carboxamides and sulphonamides |
| 02/05/2003 | CN1100771C Phosphononooxymethyl ethers for taxame derivatives |
| 02/05/2003 | CN1100770C Hydrolysis-promoitng taxane hydrophobic derivatives |
| 02/05/2003 | CN1100763C Process for producing imidazole derivatives |
| 02/05/2003 | CN1100759C Xanthene and arcridine derivative and its use |
| 02/05/2003 | CN1100758C Process for preparing [(5,6-dicarboxy 3-pyridyl) methyl] ammonium halides |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/05/2003 | CN1100747C Dialkyl ethers containing terinal caroxy or tetrazole group |
| 02/05/2003 | CN1100570C Veterinary coposition containing proton pump inhibitor |
| 02/05/2003 | CN1100564C Medicine for treating HIV infection, its composition and its use |
| 02/05/2003 | CN1100561C Apoptosis inducers |
| 02/05/2003 | CN1100552C Medicine for curing hemiparalysis |
| 02/05/2003 | CN1100543C 聚维酮碘膜剂 Povidone iodine agent |
| 02/05/2003 | CN1100542C Compositions containing at least one glucocoricoid in combination with pulmonary surfactant for treatment of IRDS and ARDS |
| 02/05/2003 | CN1100541C Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/05/2003 | CN1100539C Antifungal coposition |
| 02/05/2003 | CN1100538C Lotion |